Downgrade Alert for Fresenius Medical Care (FMS)
Fresenius Medical Care (NYSE:FMS) was downgraded from Outperform to Neutral at Exane BNP Paribas today. The stock closed yesterday at $32.11 on volume of 1.5 million shares, above average daily volume of 187,000.
Fresenius Medical Care AG & Co. KGaA offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. The Company also offers clinical laboratory testing and diagnostic testing services and provides home infusion, respiratory therapy, ultrasound, and echo-cardiography. Fresenius operates worldwide.
Over the past year, Fresenius Medical Care has traded in a range of $31.95 to $39.10 and closed yesterday at $32.11, 1% above that low. The 200-day and 50-day moving averages have moved 0.08% lower and 0.08% lower over the past week, respectively.
Fresenius Medical Care has overhead space with shares priced $32.11, or 13.9% below the average consensus analyst price target of $37.29. The stock should run into initial resistance at its 50-day moving average (MA) of $34.56 and subsequent resistance at its 200-day MA of $34.78.
SmarTrend is monitoring the recent change of momentum in Fresenius Medical Care. Please refer to our Company Overview for the results of our proprietary technical indicators that have been scanning shares of Fresenius Medical Care in search of a potential trend change.
Keywords: analyst upgrades/downgrades fresenius medical care